You haven't searched anything yet.
You are a versatile, self-motivated team player who looks forward to rolling up your sleeves. You work collaboratively with different teams and CROs to support preclinical and clinical biomarker development activities. You enjoy a fast-paced environment and are capable of juggling competing priorities. You follow up and follow through, connecting problems with solutions efficiently. You have strong interpersonal skills that allow you to effectively build working relationships inside and outside of the company.
As a Biomarker development leader, you will join the Biomarkers Team to spearhead and support projects through early to late clinical development. You will work cross-functional and serve as a bridge to discovery, translational, and clinical development teams. You will focus on projects from the start of assay development to clinical trial implementation as well as data management to ensure we are obtaining high-quality data from our clinical trials.
At Entrada, our passion for science, our devotion to patients and our values drives our behavior:
To thrive on our team, you will need to come with:
Full Time
Utilities
$144k-178k (estimate)
03/09/2024
06/28/2024
entradatx.com
MIAMI, FL
25 - 50
2016
BENNETT FELDMAN
$5M - $10M
Utilities
Entrada Therapeutics mission is to transform the treatment of devastating diseases and improve patients' quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle (EEV) platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases. The Companys novel approach addresses current challenges associated with both large and small molecule therapeutics and represents a fundamental advancement in the field of intracellular ...biologics. For more information about Entradas pipeline and the broad therapeutic potential of the Companys EEV platform, please visit www.entradatx.com .
More
Show less